Prof. Dr. med. Martin Sos - Curriculum Vitae

Education and professional career

since 2015:     W2-Professor Molecular Pathology, University of Cologne
2014 - 2015:     Junior Group Leader at the Department of Translational Genomics, University of Cologne
2013:     American Association of Cancer Research (AACR) Aflac scholar-in-training Award
2012 - 2014:     Prostate Cancer Foundation (PCF) USA, Young Investigator Award
2012 - 2014:     Postdoctoral fellow at the Howard Hughes Medical Institute, Cellular and Molecular Pharmacology, Shokat Lab, UCSF, San Francisco, CA, USA
2011 - 2013:     International Association for the Study of Lung Cancer (IASLC), Young Investigator Award
2011:     American Association of Cancer Research (AACR) Pezcoller scholar-in-training Award
2010 - 2012:     Clinical Research fellow at the Center of Integrated Oncology, Lung Cancer Group Jürgen Wolf, University of Cologne
2010:     American Association of Cancer Research (AACR) Pezcoller scholar-in-training Award
2009:     American Association of Cancer Research (AACR) scholar-in-training Award
2008:     German Association of Hematology and Oncology (DGHO) award for outstanding medical thesis
2007 - 2010:     Postdoctoral fellow at the Max-Planck-Institute for Neurological Research Cologne, Thomas Lab, Cologne
2005 - 2007:     Köln Fortune Fellowship
2004 - 2007:     Doctoral thesis: summa cum laude
2000 - 2007:     Medical school, University of Cologne

Selected publications

Sos ML, Levin RS, Gordan JD, Oses-Prieto JA, Webber JT, Salt M, Hann B, Burlingame AL, McCormick F, Bandyopadhyay S, Shokat KM. Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors. Cell Rep. 2014, Aug.

Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature. 2013, Nov.

Sos ML, Dietlein F, Peifer M, Schöttle J, Balke-Want H, Müller C, Koker M, Richters A, Heynck S, Malchers F, Heuckmann JM, Seidel D, Eyers PA, Ullrich RT, Antonchick AP, Vintonyak VV, Schneider PM, Ninomiya T, Waldmann H, Büttner R, Rauh D, Heukamp LC, Thomas RK. A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proc Natl Acad Sci USA. 2012, Oct. (co-corresponding author)

Peifer M, Fernández-Cuesta L, Sos ML et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet. 2012, Oct.

Weiss J, Sos ML, Seidel D et al. Frequent and Focal FGFR1 Amplification Associates With Therapeutically Tractable FGFR1 Dependency in Squamous-cell Lung Cancer. Sci Transl Med. 2010, Dec. (co-first and co-corresponding author)